|

F-18 16 Alpha-Fluoroestradiol Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: 16 alpha-fluroestradiol-17 beta, F-18 FES, FES, Fluorine-18 16 alpha-fluoroestradiol, Fluoroestradiol F-18

Pipeline

Phase 2: 2

Top Sponsors

  • University of Washington1
  • City of Hope Medical Center1

Indications

  • Anatomic Stage IV Breast Cancer AJCC v82
  • Breast Cancer2
  • Cancer2
  • Metastatic Hormone Receptor-Positive Breast Carcinoma1
  • Metastatic HER2 Negative Breast Carcinoma1

Duarte, California1 trial

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

City of Hope Medical Center

Phase 2

Seattle, Washington1 trial

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

Fred Hutch/University of Washington Cancer Consortium

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.